Loading viewer...
investor_presentation
Format: PDF investor_presentation
MorphoSys AG presents a company update highlighting its diverse partnership network, proprietary antibody discovery platforms (HuCAL, Ylanthia), and robust R&D pipeline. The biotech company focuses on developing differentiated therapies for cancer and inflammation with 27 antibodies in clinical development and up to 39 expected clinical readouts in 2016/2017.
investor_presentation
25 Pages
investor_presentation
47 Pages
Sappi
Enthusiast Gaming Holdings Investor Presentation 2019
investor_presentationinvestor_presentation
19 Pages
Enthusiast Gaming Holdings Inc.
investor_presentation
Pacific Nickel Mines
Shakey's Pizza Asia Ventures 2023 Investor Presentation
investor_presentationinvestor_presentation
22 Pages
Shakey's Pizza Asia Ventures, Inc.
investor_presentation
Sanofi